Osteoarthritis (Musculoskeletal) – Drugs In Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis – Drugs In Development, 2021, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.

Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Osteoarthritis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 13, 36, 23, 2, 4, 61, 15 and 2 respectively. Similarly, the Universities portfolio in Phase III, Phase I, Preclinical and Discovery stages comprises 1, 2, 8 and 7 molecules, respectively.

Osteoarthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).

– The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Musculoskeletal Disorders).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

4P-Pharma SAS

Abiogen Pharma SpA

Achelios Therapeutics Inc

Aclaris Therapeutics Inc

Adare Pharma Solutions

Akaal Pharma Pty Ltd

Akan Biosciences LLC

AKL Research and Development Ltd

Algomedix Inc

Amgen Inc

Amplicore Inc

Amzell BV

AskAt Inc

Asta Pharmaceuticals Co Ltd

Atlanthera

Aurealis Pharma AG

Axsome Therapeutics Inc

Bioiberica SAU

BioIntegrate Inc

BioNet Pharma GmbH

Bioorg3.14 LLC

BioSplice Therapeutics Inc

BioStem Technologies Inc

Bioventus Inc

Bone Therapeutics SA

BRIM Biotechnology Inc

CAR-T (Shanghai) Biotechnology Co Ltd

CarthroniX Inc

Cartilagen Inc

Causeway Therapeutics Ltd

Cells for Cells SA

CellTex Therapeutics Corp

Cellular Biomedicine Group Inc

Chondrogenix Ltd

Cmxtwenty

Cocoon Biotech, Inc.

Corestem Inc

Cynata Therapeutics Ltd

Cytonics Corp

Daewoong Pharmaceutical Co Ltd

Dianomi Therapeutics Inc

DNX Biopharmaceuticals Inc

Dongkook Pharmaceutical Co Ltd

Eli Lilly and Co

Ensol Biosciences Inc

Eternity Bioscience Inc

Evgen Pharma Plc

Flexion Therapeutics Inc

Genascence Corp

Genequine Biotherapeutics GmbH

General Regeneratives Shanghai Ltd

GlaxoSmithKline Plc

Gwoxi Stem Cell Applied Technology Co Ltd

Haplnscience Inc

Hisamitsu Pharmaceutical Co Inc

Histogen Inc

Hope Biosciences LLC

iCELL Biotechnology Co Ltd

ICM Co Ltd

Inception Therapeutics Inc

InKemia IUCT Group SA

International Stem Cell Corp

Juniper Biologics Pte Ltd

Juvena Therapeutics Inc

Kaken Pharmaceutical Co Ltd

Kang Stem Biotech Co Ltd

Kolon TissueGene Inc

Kukje Pharmaceutical Industry Co Ltd

Levolta Pharmaceuticals Inc

LG Chem Ltd

Likarda LLC

Link Biologics Ltd

Link Health Group

Lubris Biopharma

Luye Pharma Group Ltd

Magellan Biologicals Pty Ltd

MDimune Inc

Mecox Cure Med Co Ltd

Medicrinia Co Ltd

MediPost Co Ltd

Medivir AB

MeiraGTx Holdings Plc

Meluha Life Sciences Sdn Bhd

Merck KGaA

Meridigen Biotech Co Ltd

Mesoblast Ltd

MetrioPharm AG

Mor Research Applications Ltd

Nanode Therapeutics Inc

NeuroBo Pharmaceuticals Inc

New York R&D Center for Translational Medicine and Therapeutics Inc

Nordic Bioscience AS

Novartis AG

Orbsen Therapeutics Ltd

Organicell Regenerative Medicine Inc

OrthoTrophix Inc

Oxacell AG

Paradigm Biopharmaceuticals Ltd

Parnia Stem Cell Knowledge-Based Co

Peptinov SAS

Personalized Stem Cells Inc

Pfizer Inc

PhytoHealth Corp

Plakous Therapeutics Inc

PMG PHARM Co Ltd

PrimRNA Inc

Progenitor Therapeutics Ltd

ProteoThera Inc

Regeneus Ltd

Regenosine Inc

Regulaxis SAS

Ribomic Inc

Rottapharm Biotech Srl

Runjia (Suzhou) Pharmaceutical Technology Co Ltd

Sclnow Biotechnology Co Ltd

Seikagaku Corp

Serene LLC

Shionogi & Co Ltd

SL Bigen Inc

Steminent Biotherapeutics Inc

Stempeutics Research Pvt Ltd

Synartro AB

Synerkine Pharma BV

Synokem Pharmaceuticals Ltd

Taiwan Bio Therapeutics Co Ltd

Techfields Pharma Co Ltd

Traverse Biosciences Inc

Unicocell Biomed Co Ltd

Vitro Diagnostics Inc

WEX Pharmaceuticals Inc

WNT Scientific LLC

Xalud Therapeutics Inc

Xintela AB

Yooyoung Pharm Co Ltd

Zhejiang Yatai Pharmaceutical Co Ltd

Zimmer Biomet Holdings Inc

Table of Contents

Table of Contents

Introduction

Osteoarthritis - Overview

Osteoarthritis - Therapeutics Development

Osteoarthritis - Therapeutics Assessment

Osteoarthritis - Companies Involved in Therapeutics Development

Osteoarthritis - Drug Profiles

Osteoarthritis - Dormant Projects

Osteoarthritis - Discontinued Products

Osteoarthritis - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Osteoarthritis, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Osteoarthritis – Pipeline by 4P-Pharma SAS, 2021

Osteoarthritis – Pipeline by Abiogen Pharma SpA, 2021

Osteoarthritis – Pipeline by Achelios Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Aclaris Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Adare Pharma Solutions, 2021

Osteoarthritis – Pipeline by Akaal Pharma Pty Ltd, 2021

Osteoarthritis – Pipeline by Akan Biosciences LLC, 2021

Osteoarthritis – Pipeline by AKL Research and Development Ltd, 2021

Osteoarthritis – Pipeline by Algomedix Inc, 2021

Osteoarthritis – Pipeline by Amgen Inc, 2021

Osteoarthritis – Pipeline by Amplicore Inc, 2021

Osteoarthritis – Pipeline by Amzell BV, 2021

Osteoarthritis – Pipeline by AskAt Inc, 2021

Osteoarthritis – Pipeline by Asta Pharmaceuticals Co Ltd, 2021

Osteoarthritis – Pipeline by Atlanthera, 2021

Osteoarthritis – Pipeline by Aurealis Pharma AG, 2021

Osteoarthritis – Pipeline by Axsome Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Bioiberica SAU, 2021

Osteoarthritis – Pipeline by BioIntegrate Inc, 2021

Osteoarthritis – Pipeline by BioNet Pharma GmbH, 2021

Osteoarthritis – Pipeline by Bioorg3.14 LLC, 2021

Osteoarthritis – Pipeline by BioSplice Therapeutics Inc, 2021

Osteoarthritis – Pipeline by BioStem Technologies Inc, 2021

Osteoarthritis – Pipeline by Bioventus Inc, 2021

Osteoarthritis – Pipeline by Bone Therapeutics SA, 2021

Osteoarthritis – Pipeline by BRIM Biotechnology Inc, 2021

Osteoarthritis – Pipeline by CAR-T (Shanghai) Biotechnology Co Ltd, 2021

Osteoarthritis – Pipeline by CarthroniX Inc, 2021

Osteoarthritis – Pipeline by Cartilagen Inc, 2021

Osteoarthritis – Pipeline by Causeway Therapeutics Ltd, 2021

Osteoarthritis – Pipeline by Cells for Cells SA, 2021

Osteoarthritis – Pipeline by CellTex Therapeutics Corp, 2021

Osteoarthritis – Pipeline by Cellular Biomedicine Group Inc, 2021

Osteoarthritis – Pipeline by Chondrogenix Ltd, 2021

Osteoarthritis – Pipeline by Cmxtwenty, 2021

Osteoarthritis – Pipeline by Cocoon Biotech, Inc., 2021

Osteoarthritis – Pipeline by Corestem Inc, 2021

Osteoarthritis – Pipeline by Cynata Therapeutics Ltd, 2021

Osteoarthritis – Pipeline by Cytonics Corp, 2021

Osteoarthritis – Pipeline by Daewoong Pharmaceutical Co Ltd, 2021

Osteoarthritis – Pipeline by Dianomi Therapeutics Inc, 2021

Osteoarthritis – Pipeline by DNX Biopharmaceuticals Inc, 2021

Osteoarthritis – Pipeline by Dongkook Pharmaceutical Co Ltd, 2021

Osteoarthritis – Pipeline by Eli Lilly and Co, 2021

Osteoarthritis – Pipeline by Ensol Biosciences Inc, 2021

Osteoarthritis – Pipeline by Eternity Bioscience Inc, 2021

Osteoarthritis – Pipeline by Evgen Pharma Plc, 2021

Osteoarthritis – Pipeline by Flexion Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Genascence Corp, 2021

Osteoarthritis – Pipeline by Genequine Biotherapeutics GmbH, 2021

Osteoarthritis – Pipeline by General Regeneratives Shanghai Ltd, 2021

Osteoarthritis – Pipeline by GlaxoSmithKline Plc, 2021

Osteoarthritis – Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, 2021

Osteoarthritis – Pipeline by Haplnscience Inc, 2021

Osteoarthritis – Pipeline by Hisamitsu Pharmaceutical Co Inc, 2021

Osteoarthritis – Pipeline by Histogen Inc, 2021

Osteoarthritis – Pipeline by Hope Biosciences LLC, 2021

Osteoarthritis – Pipeline by iCELL Biotechnology Co Ltd, 2021

Osteoarthritis – Pipeline by ICM Co Ltd, 2021

Osteoarthritis – Pipeline by Inception Therapeutics Inc, 2021

Osteoarthritis – Pipeline by InKemia IUCT Group SA, 2021

Osteoarthritis – Pipeline by International Stem Cell Corp, 2021

Osteoarthritis – Pipeline by Juniper Biologics Pte Ltd, 2021

Osteoarthritis – Pipeline by Juvena Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Kaken Pharmaceutical Co Ltd, 2021

Osteoarthritis – Pipeline by Kang Stem Biotech Co Ltd, 2021

Osteoarthritis – Pipeline by Kolon TissueGene Inc, 2021

Osteoarthritis – Pipeline by Kukje Pharmaceutical Industry Co Ltd, 2021

Osteoarthritis – Pipeline by Levolta Pharmaceuticals Inc, 2021

Osteoarthritis – Pipeline by LG Chem Ltd, 2021

Osteoarthritis – Pipeline by Likarda LLC, 2021

Osteoarthritis – Pipeline by Link Biologics Ltd, 2021

Osteoarthritis – Pipeline by Link Health Group, 2021

Osteoarthritis – Pipeline by Lubris Biopharma, 2021

Osteoarthritis – Pipeline by Luye Pharma Group Ltd, 2021

Osteoarthritis – Pipeline by Magellan Biologicals Pty Ltd, 2021

Osteoarthritis – Pipeline by MDimune Inc, 2021

Osteoarthritis – Pipeline by Mecox Cure Med Co Ltd, 2021

Osteoarthritis – Pipeline by Medicrinia Co Ltd, 2021

Osteoarthritis – Pipeline by MediPost Co Ltd, 2021

Osteoarthritis – Pipeline by Medivir AB, 2021

Osteoarthritis – Pipeline by MeiraGTx Holdings Plc, 2021

Osteoarthritis – Pipeline by Meluha Life Sciences Sdn Bhd, 2021

Osteoarthritis – Pipeline by Merck KGaA, 2021

Osteoarthritis – Pipeline by Meridigen Biotech Co Ltd, 2021

Osteoarthritis – Pipeline by Mesoblast Ltd, 2021

Osteoarthritis – Pipeline by MetrioPharm AG, 2021

Osteoarthritis – Pipeline by Mor Research Applications Ltd, 2021

Osteoarthritis – Pipeline by Nanode Therapeutics Inc, 2021

Osteoarthritis – Pipeline by NeuroBo Pharmaceuticals Inc, 2021

Osteoarthritis – Pipeline by New York R&D Center for Translational Medicine and Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Nordic Bioscience AS, 2021

Osteoarthritis – Pipeline by Novartis AG, 2021

Osteoarthritis – Pipeline by Orbsen Therapeutics Ltd, 2021

Osteoarthritis – Pipeline by Organicell Regenerative Medicine Inc, 2021

Osteoarthritis – Pipeline by OrthoTrophix Inc, 2021

Osteoarthritis – Pipeline by Oxacell AG, 2021

Osteoarthritis – Pipeline by Paradigm Biopharmaceuticals Ltd, 2021

Osteoarthritis – Pipeline by Parnia Stem Cell Knowledge-Based Co, 2021

Osteoarthritis – Pipeline by Peptinov SAS, 2021

Osteoarthritis – Pipeline by Personalized Stem Cells Inc, 2021

Osteoarthritis – Pipeline by Pfizer Inc, 2021

Osteoarthritis – Pipeline by PhytoHealth Corp, 2021

Osteoarthritis – Pipeline by Plakous Therapeutics Inc, 2021

Osteoarthritis – Pipeline by PMG PHARM Co Ltd, 2021

Osteoarthritis – Pipeline by PrimRNA Inc, 2021

Osteoarthritis – Pipeline by Progenitor Therapeutics Ltd, 2021

Osteoarthritis – Pipeline by ProteoThera Inc, 2021

Osteoarthritis – Pipeline by Regeneus Ltd, 2021

Osteoarthritis – Pipeline by Regenosine Inc, 2021

Osteoarthritis – Pipeline by Regulaxis SAS, 2021

Osteoarthritis – Pipeline by Ribomic Inc, 2021

Osteoarthritis – Pipeline by Rottapharm Biotech Srl, 2021

Osteoarthritis – Pipeline by Runjia (Suzhou) Pharmaceutical Technology Co Ltd, 2021

Osteoarthritis – Pipeline by Sclnow Biotechnology Co Ltd, 2021

Osteoarthritis – Pipeline by Seikagaku Corp, 2021

Osteoarthritis – Pipeline by Serene LLC, 2021

Osteoarthritis – Pipeline by Shionogi & Co Ltd, 2021

Osteoarthritis – Pipeline by SL Bigen Inc, 2021

Osteoarthritis – Pipeline by Steminent Biotherapeutics Inc, 2021

Osteoarthritis – Pipeline by Stempeutics Research Pvt Ltd, 2021

Osteoarthritis – Pipeline by Synartro AB, 2021

Osteoarthritis – Pipeline by Synerkine Pharma BV, 2021

Osteoarthritis – Pipeline by Synokem Pharmaceuticals Ltd, 2021

Osteoarthritis – Pipeline by Taiwan Bio Therapeutics Co Ltd, 2021

Osteoarthritis – Pipeline by Techfields Pharma Co Ltd, 2021

Osteoarthritis – Pipeline by Traverse Biosciences Inc, 2021

Osteoarthritis – Pipeline by Unicocell Biomed Co Ltd, 2021

Osteoarthritis – Pipeline by Vitro Diagnostics Inc, 2021

Osteoarthritis – Pipeline by WEX Pharmaceuticals Inc, 2021

Osteoarthritis – Pipeline by WNT Scientific LLC, 2021

Osteoarthritis – Pipeline by Xalud Therapeutics Inc, 2021

Osteoarthritis – Pipeline by Xintela AB, 2021

Osteoarthritis – Pipeline by Yooyoung Pharm Co Ltd, 2021

Osteoarthritis – Pipeline by Zhejiang Yatai Pharmaceutical Co Ltd, 2021

Osteoarthritis – Pipeline by Zimmer Biomet Holdings Inc, 2021

Osteoarthritis – Dormant Projects, 2021

Osteoarthritis – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Osteoarthritis, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports